M K Proteins Share Price ₹4.07 | P/E 31.6

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of M K Proteins

Quarter-by-quarter operating performance

	Mar 2017	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales +	53.59	76.20	13.64	68.86	86.87	57.33	33.69	39.48	137.20	114.95	32.43	89.56
Expenses +	51.69	72.21	13.00	65.30	78.44	53.59	31.46	37.69	132.55	109.44	31.39	87.19
Operating Profit	1.90	3.99	0.64	3.56	8.43	3.74	2.23	1.79	4.65	5.51	1.04	2.37
OPM %	3.55%	5.24%	4.69%	5.17%	9.70%	6.52%	6.62%	4.53%	3.39%	4.79%	3.21%	2.65%
Other Income +	0.01	0.00	0.03	0.01	0.41	0.00	0.21	0.25	0.02	0.00	0.12	0.02
Interest	0.69	0.52	0.04	0.11	0.40	0.33	0.03	0.07	0.67	0.70	0.06	0.30
Depreciation	0.30	0.12	0.12	0.12	0.18	0.07	0.07	0.11	0.09	0.10	0.11	0.12
Profit before tax	0.92	3.35	0.51	3.34	8.26	3.34	2.34	1.86	3.91	4.71	0.99	1.97
Tax %	36.96%	25.67%	21.57%	25.75%	29.42%	25.45%	25.21%	25.81%	28.64%	25.27%	25.25%	26.90%
Net Profit +	0.57	2.49	0.41	2.48	5.83	2.48	1.74	1.38	2.80	3.51	0.75	1.43
EPS in Rs	0.02	0.07	0.01	0.07	0.16	0.07	0.05	0.04	0.07	0.09	0.02	0.04

Financials of M K Proteins

Annual income statement trend

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	122	123	145	165	172	157	194	311	256	315	245	268	374
Expenses +	119	119	141	160	166	152	189	295	240	298	229	255	361
Operating Profit	3	4	4	5	6	5	5	16	16	17	17	13	14
OPM %	2%	3%	3%	3%	3%	3%	2%	5%	6%	5%	7%	5%	4%
Other Income +	0	0	0	0	0	0	0	0	0	1	0	0	0
Interest	2	2	2	2	2	2	2	1	1	2	1	1	2
Depreciation	0	1	1	1	1	1	1	1	1	1	1	0	0
Profit before tax	1	1	1	2	2	2	2	14	14	15	15	11	12
Tax %	33%	32%	31%	35%	35%	28%	26%	27%	27%	27%	28%	27%
Net Profit +	0	1	1	1	1	2	2	10	10	11	11	8	8
EPS in Rs	0.82	1.40	1.20	0.04	0.04	0.04	0.05	0.28	0.27	0.29	0.30	0.22	0.22
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Financials of M K Proteins

Capital structure and asset base

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	0.68	0.68	0.68	3	4	4	4	4	4	13	38	38	38
Reserves	1	2	3	2	11	13	15	25	35	37	24	32	36
Borrowings +	28	20	26	31	33	26	31	25	37	46	20	39	2
Other Liabilities +	2	13	10	12	8	4	7	13	10	8	15	22	4
Total Liabilities	32	35	39	47	56	47	57	67	86	103	96	131	80
Fixed Assets +	3	6	7	7	6	4	3	2	3	3	3	4	3
CWIP	3	0	0	0	0	0	0	0	0	0	6	7	7
Investments	0	0	0	0	0	0	0	0	0	0	0	0	4
Other Assets +	26	29	32	40	50	43	53	65	83	100	88	120	66
Total Assets	32	35	39	47	56	47	57	67	86	103	96	131	80

Financials of M K Proteins

Operating, investing and financing cash movement

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-5	11	-4	-4	-12	6	-4	6	-10	-6	32	-16
Cash from Investing Activity +	-3	-0	-2	-1	-0	0	0	-0	-2	0	-6	-1
Cash from Financing Activity +	8	-10	6	5	12	-7	4	-5	12	6	-27	18
Net Cash Flow	-0	-0	0	-0	0	-0	0	-0	0	0	0	-0
Free Cash Flow	-8	10	-6	-5	-12	6	-4	5	-12	-6	27	-18
CFO/OP	-179%	267%	-92%	-65%	-202%	150%	-77%	44%	-39%	-6%	216%	-95%

Financials of M K Proteins

Working capital efficiency and return ratios

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	19	16	27	10	39	25	18	24	42	19	5	2
Inventory Days	62	70	57	83	69	75	79	48	80	91	134	170
Days Payable	6	39	22	23	12	6	8	10	8	6	19	29
Cash Conversion Cycle	75	47	62	70	97	94	89	62	114	104	120	142
Working Capital Days	69	11	9	20	44	32	36	36	55	57	77	81
ROCE %	10%	14%	13%	12%	11%	8%	8%	29%	23%	20%	19%	13%

Dwarikesh Sugar Industries Ltd (Q4 FY23)
If you can provide a valid transcript or document, I will be happy to assist with your query. Key concall takeaways from Dwarikesh Sugar Industries Ltd's Q4…
Dwarikesh Sugar Industries Ltd (Q3 FY23)
The provided PDF page contains a "500 . Key concall takeaways from Dwarikesh Sugar Industries Ltd's Q3 FY23 earnings call — and how it ranks against sector…
Chamanlal Setia Exports Ltd (Q1 FY27)
Management is optimistic about sustaining EBITDA margins (12-14%) with profitable business mix. Key concall takeaways from Chamanlal Setia's Q1 FY27 earnings…
Kaveri Seed Company Ltd (Q1 FY27)
100 crores revenue in vegetables within 3 to 5 years. Key concall takeaways from Kaveri Seed Company Ltd's Q1 FY27 earnings call — and how it ranks against…

M K Proteins Share Price & Earnings Call Analysis